Trials / Completed
CompletedNCT01110733
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (actual)
- Sponsor
- Acrotech Biopharma Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
Detailed description
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2010-04-27
- Last updated
- 2020-01-13
Locations
68 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01110733. Inclusion in this directory is not an endorsement.